Abstract Reactive oxygen species damage various cell components including DNA, proteins, and lipids, and these impairments could be a reason for severe human diseases including atherosclerosis. Forkhead box O1 (FOXO1), an important metabolic transcription factor, upregulates antioxidant and proapoptotic genes during oxidative stress. Apolipoprotein A-I (ApoA-I) forms high density lipoprotein (HDL) particles that are responsible for cholesterol transfer from peripheral tissues to liver for removal in bile in vertebrates. The main sources for plasma ApoA-I in mammals are liver and jejunum. Hepatic apoA-I transcription depends on a multitude of metabolic transcription factors. We demonstrate that ApoA-I synthesis and secretion are decreased during H 2 O 2 -induced oxidative stress in human hepatoma cell line HepG2. Here, we first show that FOXO1 binds to site B of apoA-I hepatic enhancer and downregulates apoA-I gene activity in HepG2 cells. Moreover, FOXO1 and LXRα transcription factors participate in H 2 O 2 -triggered downregulation of apoA-I gene together with Src, JNK, p38, and AMPK kinase cascades.
Introduction
Oxidative stress is a state in which cells are not capable to inactivate reactive oxygen and nitrogen species (ROS and NOS) formed by oxidative metabolism. ROS damage various cell components including DNA, proteins, and lipids, and these impairments could be a reason for severe human diseases including atherosclerosis. Moreover, some ROS can be involved in redox signaling as second messengers, so oxidative stress disturbs normal signal transduction in the cells (Rani et al. 2016) . Hydrogen peroxide, hydroxyl radical, and superoxide anion are the important members of ROS family. H 2 O 2 assists inflammatory response by inactivating phosphatases as well as activating specific signaling cascades (Kyriakis and Avruch 2012; Schieber and Chandel 2014) . Hydrogen peroxide is produced by NADPH-oxidases in hepatocytes as a response to proinflammatory or hormone stimuli (Bedard and Krause, 2007; Schieber and Chandel, 2014) . Although the release of reactive oxygen species was recognized as a critical step in combating invaders, excessive production of ROS can trigger oxidative stress that causes significant harm to cells (Schieber and Chandel 2014) . Additionally, inflammation is now considered to be one of the main causes of metabolic syndrome, and hyperactivation of proinflammatory signaling pathways might be responsible for this process (Donath and Shoelson 2011) .
Apolipoprotein A-I (ApoA-I) forms high density lipoprotein (HDL) particles that are responsible for the cholesterol transfer from peripheral tissues to liver for removal in bile in vertebrates (Lewis and Rader 2005) . HDLs protect peripheral tissues from accumulation of excess cholesterol and subsequent development of atherosclerosis. ApoA-I also manifests anti-inflammatory and anti-thrombotic activities that contribute to its key role in preventing atherosclerosis development (Hopkins 2013; Kontush and Chapman 2006) .
The main sources for plasma ApoA-I in mammals are liver and jejunum (Eggerman et al. 1991; Ginsburg et al. 1995) . Recently, synthesis of ApoA-I was found in human macrophages where endogenous ApoA-I restricts macrophage response to proinflammatory stimuli and stabilizes cassette transporter ABCA1 (Mogilenko et al. 2012b ). Treatment of hepatic cells with TNFα, IL-1β, or a bacterial lipopolysaccharide decreases the rates of ApoA-I expression and secretion (Haas et al. 2003; Mogilenko et al. 2009; Morishima et al. 2003; Orlov et al. 2010; Song et al. 1998) .
Hepatic enhancer (HE) was shown to be the main element controlling apoA-I transcription in liver cells. HE is located in coordinates−222…−110 versus the canonical site of transcription initiation. There are three main regions within HE: sites A (−214…−192), B (−169…−146), and C (−134…−119) (Higuchi et al. 1988; Sastry et al. 1988; Widom et al. 1991) . Metabolic regulators from nuclear receptor superfamily LXRα and LXRβ (Huuskonen et al. 2006 ) decrease apoA-I expression through binding to site C, PPARα (Martin et al. 2001) activates apoA-I transcription by interacting with site A, while HNF4α (Chan et al. 1993; Malik and Karathanasis 1996) upregulates, and PPARγ inhibits (Shavva et al. 2016b ) apoA-I expression through binding to both sites A and C. Proinflammatory agents repress apoA-I in HepG2 cells by employing nuclear receptors that interact with sites A and C of HE (Mogilenko et al. 2009; Morishima et al. 2003; Orlov et al. 2010; Shavva et al. 2016b ). Activators of apoA-I expression FOXA2 (Harnish et al. 1994; Harnish et al. 1996) and Sp1 (Oleaga et al. 2013) were shown to bind site B.
Little is known about apoA-I gene expression under oxidative stress. Administration of an oxidative stress inducer, gramoxone, to human hepatoma cells results in the simultaneous activation of apoA-I transcription and ApoA-I mRNA degradation (Cuthbert et al. 1997 ). Interestingly, a putative Bantioxidant response element^(ARE) within the HE (−145...−130) may be involved in gramoxone-mediated induction of apoA-I transcription (Cuthbert et al. 1997) . However, gramoxone is not an endogenous compound and is not found in vivo. Moreover, there is no data confirming the relevance of the gramoxone model to oxidative stress in vivo.
FOXO1 was implicated in protecting cells from excessive ROS production (Choi et al. 2009; Klotz et al. 2015) and mediating the apoptosis induced by oxidative stress (Shen et al. 2012) . FOXO1 was shown to upregulate several survival genes, responsible for defense against excessive ROS accumulation, namely HO-1 (Cheng et al. 2009; Liu et al. 2013) , catalase (Awad et al. 2014) , and MnSOD (Sengupta et al. 2011) . Despite the clear importance of FOXO1 in maintenance of hepatic cholesterol and glucose homeostasis, its role in the modulation of apoA-I gene expression is still unknown. Some of key FOXA2 target genes are also regulated by FOXO1 including GK, PEPK, and G6Pase (Hirota et al. 2008; Schmoll et al. 2000; Yeagley et al. 2001 ). FOXA2 and FOXO1 compete for the common binding site in Pdx2 promoter in pancreatic β-cells (Kitamura and Ido Kitamura 2007) .
Here, we show that treatment of human hepatoma cells (HepG2 cell line) with hydrogen peroxide leads to the repression of ApoA-I synthesis and secretion. This effect depends on FOXO1 and LXRα transcription factors. Moreover, we have first found that FOXO1 binds to site B of apoA-I HE and inhibits apoA-I gene transcription. Mutations of sites B or C as well as transfection of HepG2 cells by siRNAs against FOXO1 or LXRα abolished the suppression of apoA-I gene by hydrogen peroxide.
Materials and methods
Chemical inhibitors MAP-kinase inhibitors were purchased from Biomol, USA: SP600125 (JNK1/2/3 inhibitor)-cat. number EI-305; SB203580 (p38 inhibitor) -cat. number EI-286; U0126 (MEK1/2 inhibitor)-cat. number EI-282; PP2 (Src inhibitor)-cat. number SIH-470.
Antibodies Mouse monoclonal antibodies against human β-actin (cat. number ab3280) were supplied by Abcam. Rabbit polyclonal antibodies against human FOXO1 (cat. number sc-11350) were purchased from Santa Cruz Biotechnology.
Plasmids The pCMVLacZ plasmid (Dizhe et al. 2006 ) and pA1(−256/+72) (Lapikov et al. 2008) were described elsewhere. The plasmids pA1(−256/+72) with disrupted A or C sites (Shavva et al. 2016b ) and B site (Shavva et al. 2016a) were described in the previous works.
Cell culture maintenance and electroporation Human hepatoma cell line HepG2 was purchased from the Cell Culture Bank of the Institute of Cytology, Russian Academy of Sciences, Saint-Petersburg, Russia. The details of HepG2 cultivation and electroporation as well as a luciferase test were described earlier (Shavva et al. 2016b ). The following concentrations of kinase inhibitors were used: SP600125 (10 μM), U0126 (10 μM), SB203580 (25 μM), and PP2 (10 μM). The inhibitors were added to cells 1 h before hydrogen peroxide administration.
MTT assay HepG2 cells were seeded into 96-well plates at a density of 1 × 10 4 cells/cm 2 in DMEM with 10% fetal calf serum (FCS) in 5% CO 2 at 37°C. After 24 h incubation, culture medium was changed to fresh DMEM without FCS and cells were cultured for 24 h. Culture medium was changed to fresh DMEM without FCS again; different concentrations of hydrogen peroxide were added to cells, and the cell viability was accessed by MTT assay after 24 h incubation as described (Mosmann 1983) . Briefly, one half of the culture medium (100 μl) was removed from wells and 20 μl of MTT (3-(4,5-dimethylthiazol-2-yl)-diphenyltetrazolium bromide) (Sigma) solution (5 mg/ml on phosphate saline buffer, pH 8.0) was added. Cells were incubated at 37°C for 4 h and the medium with dye was removed. Cells were lysed in 200 μl of DMSO and absorbance at 570 nm was measured by Synergy 2 plate reader (Bio-Tek Instruments). The cell death (in %) was calculated by following formula:
where D 570 is the absorbance at 570 nm in a sample well, D 570 DMEM is the absorbance at 570 nm in a well without cells (fresh DMEM), and D 570 K is the absorbance at 570 nm in a well with control untreated HepG2 cells.
siRNA-mediated knockdown Scrambled control RNA oligonucleotides (sc-37007) and siRNA against FOXO1 (sc-35382) were supplied by Santa Cruz Biotechnology. siRNA against AMPKα1 and AMPKα2 (Tangeman et al. 2012 ) was purchased from DNA-Synthesis (Moscow, Russia). The Lipofectamine RNAiMAX (Invitrogen) was used for delivery of siRNAs into cells in accordance to manufacturer's instructions. The cells were harvested 72 h after transfection.
Reverse transcription and real time PCR RNA isolation, reverse transcription, and real-time PCR including multiplexing details were performed as described earlier (Mogilenko et al. 2013; Shavva et al. 2016b) . Primers for human β-actin (Mogilenko et al. 2012a) , human RPLP0, human Cyclophilin A (Shavva et al. 2016b) , and human ApoA-I (Mogilenko et al. 2009 ) were described earlier. Primers for human FOXO1: 5′-AACCAAAGCTTCCCACACAG-3′, 5′-GTAACCTGCTCACTAACCCTCAG-3′ , 5′ -ROX-GACAACGACACATAGCTGGGTGTCAGG-RTQ2-3′; AMPKα1: 5′-TGGATTTCCGTAGTATTGATGATG-3′, 5′-CCAGGTCTTGGAGTTAGGTCA-3′; AMPKα2: 5′-TGGA C T T TA A A A G C AT T G AT G AT G -3 ′ , 5′ -A G G C GAGGTGAAACTGAAGA-3′; and MnSOD2: 5′-TGCA AGGAACAACAGGCC-3′, 5′-CGTGGTTTACTTTT TGCAAGC-3′ were selected by Primer3 software (http://primer3.sourceforge.net).
ChIP assay Chromatin immunoprecipitation (ChIP) was performed as described (Mogilenko et al. 2009 ). Primers for apoA-I HE were published elsewhere (Mogilenko et al. 2009 ); for human G6Pase promoter region containing FOXO1 RE: 5′-CTGTGTCTCTGGCCTGGTTT-3′ and 5′-CAACCCAGCCCTGATCTTT-3′. Non-specific binding was assessed with the use of antibodies against human β-actin and by primers to GAPDH pseudogene.
Nuclear extract preparation and DNA affinity precipitation Nuclear extracts were obtained as described elsewhere (Andrews and Faller, 1991) . DNA affinity precipitation was performed as described earlier (Orlov et al. 2007 ). The following double-stranded synthetic oligonucleotides were used (sequences of sense strands only are shown): HRE-B 5′-TTTG CCCACTCTATTTGCCCAGCCCCATG-3′ (matches to site B of HE) or HRE-B-mut, 5′-TTTGCTGTGAGTCCACTCTATT TGCCCAG-3′ (mutated site B; altered nucleotides are underlined). All oligonucleotides were obtained from Syntol. Western blotting was used for the analysis of the samples.
Enzyme-linked immunosorbent assay (ELISA)
Determination of ApoA-I concentration in the cultural medium or cell lysates was performed by ELISA as described earlier (Mogilenko et al. 2009 ). Polyclonal antibodies to human apoA-I were obtained as described previously (McVicar et al. 1984 ).
Statistical analysis Results are shown as means ± standard error of mean. The group comparisons were performed by an unpaired t test or Dunnett's criterion (for multiple comparisons). The values of p < 0.05 were accepted for statistically significant differences. Statistical analysis was carried out by Statistica 5.0 software (StatSoft).
Results and discussion
Hydrogen peroxide downregulates apoA-I expression in concentration-dependent manner in HepG2 cells
Gramoxone, an inducer of oxidative stress, activates apoA-I gene but destabilized its mRNA, resulting in overall decrease in the amount of ApoA-I mRNA in HepG2 cells (Cuthbert et al. 1997) . To investigate the effect of ROS on apoA-I gene activity we treated HepG2 cells with H 2 O 2 for 24 h. This term was chosen because of rather high stability of ApoA-I mRNA (ApoA-I mRNA half life is about 23 h (Cuthbert et al. 1997) ). Toxicity of H 2 O 2 was assessed using MTT test (Fig. 1a) . Only a high (1.5 mM) concentration of hydrogen peroxide appeared to be toxic (Fig. 1a) . Treatment of HepG2 cells with 250 μM of hydrogen peroxide resulted in an increase of MnSOD2 mRNA levels, indicating that this amount of H 2 O 2 provoked the oxidative stress response (Fig. 1b) . Administration of 20-100 μM of hydrogen peroxide failed to affect apoA-I gene expression, while 250 μM triggered a decrease in gene activity. There were no significant differences between 250 and 500 μM concentrations of hydrogen peroxide and this fact is in a good agreement with threshold model of oxidative stress induction (Fig. 1c) .
To see if mRNA level alteration was in parallel with decrease in protein content and secretion, we measured the amount of secreted and intracellular ApoA-I protein by ELISA. The concentration of ApoA-I protein in cellular extracts and cultivation medium was decreased after treatment with 500 μM of H 2 O 2 (Fig. 1d, e) . Interestingly, treatment of HepG2 cells with 50 μM of hydrogen peroxide resulted in a modest increase in ApoA-I secretion (Fig. 1e) . This effect might be a result of an independent regulation of ApoA-I secretion as it had been shown earlier for different stimuli (Mogilenko et al. 2009; Shavva et al. 2016a; Shavva et al. 2016b) .
To ensure the energy-dependent rather than passive (induced by the loss of plasma membrane integrity during hydrogen peroxide exposure) mechanism of ApoA-I secretion, cells were treated with sodium azide (10 mM) (blocks oxidative phosphorylation). Treatment of HepG2 cells with sodium azide led to the almost complete absence of secreted ApoA-I in culture medium, that suggests an energy-dependent mechanism of ApoA-I secretion (Fig. 1f) .
Hydrogen peroxide activates Src, p38, JNK, and AMPK to downregulate apoA-I gene expression
Oxidative stress is known to employ several different signaling pathways to regulate gene expression. Stress-regulated MAP-kinases of JNK and p38 families are activated by ASK1/2/MKK4/7 and ASK1/2/MKK3/6 pathways respectively (Kyriakis and Avruch 2012) . Another MAPK Erk1/2 are phosphorylated in the response to ROS by Src/Ras signaling (Aikawa et al. 1997) . Moreover, p38 and JNK MAPK can also be activated by Src under oxidative stress (Kim et al. 2008; Yoshizumi et al. 2000) . Both Ask1/2 and Src are activated by similar mechanisms, where ROS oxidize cysteine residues on Trx (in the case of Ask1/2) to release kinases from Trx-dependant inhibition or on Src itself to allow for autophosphorylation and activation (Giannoni et al. 2005; Kyriakis and Avruch 2012) . We treated HepG2 cells with inhibitors of Src (PP2), JNK1/2/3 (SP600125), MEK1/2 (U0126), and p38 (SB203580) to evaluate their possible involvement in the apoA-I gene repression by hydrogen peroxide (Fig. 2a, b) . Pretreatment of HepG2 cells with JNK, p38, or Src inhibitors weakened the hydrogen peroxide-mediated decrease in apoA-I gene activity (Fig. 2a, b) . In contrast, MEK1/2 inhibitor failed to interfere with apoA-I expression downregulation under hydrogen peroxide (Fig. 2a) .
The other potential target of oxidative stress is AMPactivated protein kinase (AMPK) (Han et al. 2010 ). The Values are presented as means ± the standard error of the mean of three independent experiments. The statistical analyses of differences between compared groups were performed using a non-paired Student's t test (**p < 0.05) possible role of AMPK in apoA-I gene expression decrease during oxidative stress was assessed by transfecting HepG2 cells with siRNA against two isoforms of catalytic subunit of AMPK-α1 and α2 (Fig. 2d-f) . siRNA decreased the amounts of AMPKα mRNAs as well as AMPKα protein (Fig. 2d-f ) and canceled hydrogen peroxide-induced downregulation of apoA-I expression (Fig. 2c) , indicating that AMPK is involved in this process.
Transcription factors FOXO1 and LXRα mediate repression of apoA-I gene by H 2 O 2
Transcription factor FOXO1 protects cells during oxidative stress by increasing production of Catalase, HO-1, and MnSOD (Awad et al. 2014; Cheng et al. 2009; Liu et al. 2013; Sengupta et al. 2011; Klotz et al. 2015) . The nucleocytoplasmic translocation plays an important role in the FOXO1-dependent transcriptional regulation. The most important signal cascade controlling FOXO1 nucleocytoplasmic translocation is phosphatidylinositol 3-kinase/ protein kinase B (PI3K/PKB) pathway that results in the phosphorylation of FOXO1 at Thr24, Ser256, and Ser319 and the exclusion of phosphorylated FOXO1 from nucleus to cytoplasm with its following proteasomal degradation (Rena et al. 1999) . However, while this signal pathway plays a central role in the FOXO1 inactivation under cell administration of insulin or other growth factors, it appears not to be involved in the FOXO1 regulation under oxidative stress. Moreover, phosphorylation of FOXO1 by MST1 (Lehtinen et al. 2006) or methylation by PRMNT1 (Yamagata et al. 2008 ) protect FOXO1 from the protein kinase B-mediated phosphorylation at Ser256 in the response to oxidative stress and prevent FOXO1 nuclear exclusion.
P38, JNK and AMPK may be implicated in FOXO1-dependent signaling during oxidative stress. MAP-kinases, Erk1/2, and p38, but not JNK, phosphorylate and activate FOXO1 (Asada et al. 2007 ). Nevertheless, FOXO1 and JNK appear to cooperate during a stress response in multiple cell types (Martinez et al. 2008; Yinghua et al. 2014) . JNK was shown to phosphorylate FOXO4 (Essers et al. 2004 ), but not FOXO1 (Asada et al. 2007 ). JNK-mediated activation of FOXO1 might depend on its ability to phosphorylate 14-3-3ζ, a protein known to induce FOXO1 nuclear-cytoplasmic translocation and Values are presented as means ± the standard error of the mean of three independent experiments. The statistical analyses of differences between compared groups were performed using a non-paired Student's t -test (**p < 0.05; #p < 0.01; N.S. non-significant (p > 0.05)) inactivation (Van Der Heide et al. 2004 ). Phosphorylation of 14-3-3ζ by JNK was shown to trigger the release of a related forkhead factor FOXO3a (Sunayama et al. 2005) , suggesting that similar mechanism might be possible for FOXO1. AMPK was shown to activate FOXO1 in pulmonary arterial myocytes in response to hypoxiagenerated hydrogen peroxide (Awad et al. 2014) . Whether AMPK directly phosphorylates FOXO1 or activates it through any other mechanism is unknown. However, inhibition of AMPK resulted in a decrease in FOXO1 activity (Awad et al. 2014) . Taking into account our data about the role of AMPK and MAP kinases p38, and JNK in the downregulation of apoA-I expression under oxidative stress (Fig. 2) , it is plausible to suggest that FOXO1 is responsible for this effect.
To study the role of FOXO1 in apoA-I transcription inhibition during oxidative stress, we employed siRNA-mediated knockdown of FOXO1. siRNA against FOXO1 decreased both FOXO1 mRNA and protein levels (Fig. 3a, b) . Additionally, siRNA against FOXO1 downregulated the canonical FOXO1 target gene G6Pase (Fig. 3c) . siRNA against FOXO1 led to~20% elevation in ApoA-I mRNA suggesting that FOXO1 might be a repressor of apoA-I gene (Fig. 3d) . Administration of hydrogen peroxide to HepG2 cells repressed apoA-I gene while siRNA against FOXO1 abrogated this effect (Fig. 3d) . These data indicate that the hydrogen peroxide-mediated downregulation of apoA-I gene expression is FOXO1-dependent.
The other putative target of AMPK under oxidative stress is transcription factor LXRα. AMPK was shown to phosphorylate and inactivate LXRα (Hwahng et al. 2009 ). To see if LXRα might be responsible for downregulation of apoA-I gene during oxidative stress, we transfected HepG2 cells with siRNA against LXRα or scrambled siRNA and treated them with hydrogen peroxide for 24 h (Fig. 3e-g ). siRNA against LXRα significantly decreased the amount of LXRα mRNA (Fig. 3e) and protein (Fig. 3f) and completely abrogated hydrogen peroxide-induced decrease in apoA-I gene activity Values are presented as means ± the standard error of the mean of three independent experiments. The statistical analyses of differences between compared groups were performed using a non-paired Student's t test (**p < 0.05; #p < 0.01) b (Fig. 3g) , showing that LXRα is indeed important for the repression of apoA-I gene under an oxidative stress.
FOXO1 binds to the site B of hepatic enhancer
FOXO1-related transcription factor FOXA2 is capable of interacting with site B of HE (Harnish et al. 1994; Harnish et al. 1996) . Given the close DNA-binding specificity of FOXO1 and FOXA2, site B of HE is likely to be a putative binding site for FOXO1. Moreover, we have shown the role of FOXO1 in the insulin-dependent regulation of apoA-I gene earlier (Shavva et al. 2016a ). To test whether FOXO1 can bind to site B in vitro, we performed DNA-affinity precipitation. As shown on Fig. 4a,  FOXO1 is capable of specifically binding site Bcontaining probes. While addition of the excess amount of unlabeled oligonucleotide corresponding to site B diminished the amount of bound FOXO1, mutated oligonucleotide failed to compete with the biotin-containing probe. To test the capacity of FOXO1 to bind HE in vivo, we employed chromatin immunoprecipitation assay (ChIP) (Fig. 4b) . The G6Pase promoter that contains sites for FOXO1 (Vander Kooi et al. 2003 ) was selected as a positive control. ChiP confirmed that FOXO1 interacts with the HE of apoA-I and the G6Pase promoter in vivo. Hydrogen peroxide failed to affect FOXO1 binding to the HE (Fig. 4b) . Based on the above mentioned results, we can conclude that FOXO1 binds to the HE of apoA-I gene in HepG2 cells in vivo.
Hydrogen peroxide downregulates apoA-I gene expression through the sites B and C apoA-I gene expression in hepatocytes is mainly controlled by the hepatic enhancer. To test the possible role of the HE in the hydrogen peroxide-mediated repression of apoA-I gene, we transfected HepG2 cells with the plasmid bearing the reporter gene encoding luciferase driven by the intact HE (pA1(−256/+72)) or by the HE with disrupted sites A (pA1(−256/+72) mutA), B (pA1(−256/+72) mutB), or C (pA1(−256/+72) mutC) (Fig. 5a) . Expression of the reporter gene under the control of intact HE was significantly suppressed in cells treated with H 2 O 2 compared to the control cells, indicating that HE is sufficient for hydrogen peroxidemediated repression of the apoA-I gene (Fig. 5b) . All three mutations significantly suppressed luciferase activity (Fig. 5a ). Hydrogen peroxide downregulated apoA-I HE activity in cells transfected with pA1(−256/+72) mutA (Fig. 5c ), yet increased luciferase expression in cells transfected with pA1(−256/+72) mutB (Fig. 5d ) and pA1(−256/+72) mutC (Fig. 5e) . The experiments with plasmid constructs suggest that sites B and C participate in H 2 O 2 -dependent downregulation of apoA-I expression.
We have shown that FOXO1 binds site B of the HE in HepG2 cells (Fig. 4a, b) , and LXRα was earlier shown to bind to site C (Huuskonen et al. 2006) . Moreover, we have demonstrated that both FOXO1 (Fig. 3d) and LXRα (Fig. 3g) are necessary for H 2 O 2 -induced repression of apoA-I gene in HepG2 cells. These data are in agreement with the necessity of both sites B and C (Fig. 5d, e) for the decrease in apoA-I promoter activity during oxidative stress.
AMPK downregulates apoA-I expression through LXRα
AMPK was shown to regulate both LXRα (Hwahng et al. 2009 ) and FOXO1 (Awad et al. 2014) . To determine the transcription factor through which hydrogen peroxide-induced AMPK downregulates apoA-I expression, we transfected cells Primers to GAPDH genomic DNA were used as non-specificity control. AB against β-actin were used as the control for non-specific binding. Values are presented as means ± the standard error of the mean of three independent experiments. The statistical analyses of differences between compared groups were performed using a non-paired Student's t -test. There are no significant differences between levels of FOXO1 binding to apoA-I HE in the control cells and in the cells under oxidative stress with siRNA against FOXO1, LXRα, or AMPK and treated them with either hydrogen peroxide or a well-known AMPK activator metformin (Fig. 6a) . Treatment of HepG2 cells with metformin for 24 h resulted in the significant decrease in apoA-I gene activity, confirming that treatment of HepG2 cells with AMPK activators leads to suppression of apoA-I expression. According to the previous experiments (Figs. 2 and 3 ), knockdown of all three genes resulted in abolishment of H 2 O 2 -driven decrease in apoA-I expression. However, only siRNAs against LXRα or AMPK canceled metformininduced downregulation of apoA-I transcription. These experiments show that activation of AMPK by hydrogen peroxide or metformin results in the downregulation of apoA-I expression through LXRα activation. Interestingly, AMPK-induced LXRα phosphorylation prevented the induction of several LXRα target genes by its ligand (Hwahng et al. 2009 ). However, we have shown that LXRα binds to apoA-I HE in complex with FOXA2 and FOXA2 is necessary for the downregulation of apoA-I expression by LXRα ligand (Shavva et al. 2016a) . LXRα bound to FOXA2 may behave differently from its other forms.
JNK induces FOXO1 nuclear translocation but fails to affect its binding to apoA-I HE JNK may participate in the hydrogen peroxide-mediated downregulation of apoA-I gene expression by promoting FOXO1 nuclear localization (see above). To check this assumption, cells were pretreated for 1 hour with JNK inhibitor SP600125 before addition of H 2 O 2 and harvested 2 hours later. Hydrogen peroxide treatment triggered FOXO1 translocation from cytoplasm to the nucleus. Pretreatment with JNK inhibitor prevented this effect (Fig. 6b) . These data confirm the involvement of JNK in nuclear accumulation of FOXO1 during oxidative stress possibly by phosphorylation of 14-3-3ζ. To assess the role of JNK in promoting FOXO1 binding to apoA-I HE, chromatin immunoprecipitation was performed. In agreement with earlier experiments (Fig. 4b) , hydrogen peroxide treatment had no significant effect on FOXO1 binding to HE, and pretreatment of HepG2 cells with SP600125 had no effect either (Fig. 6c) . Similar results were obtained with LXRα (Fig. 6d) . The possible reason for this discrepancy (the decrease of nuclear FOXO1 caused by JNK inhibitor under oxidative stress does not lead to departure of FOXO1 from apoA-I HE) is the fact that FOXO1 interacts with HE of apoA-I as part of a complex with LXRβ that can attach FOXO1 to the HE of apoA-I (Shavva et al. 2016a ). However, knockdown of LXRβ does not prevent the hydrogen peroxide-mediated downregulation of apoA-I gene expression (data not shown). Alternatively, direct or indirect effects of JNK on FOXO1 under oxidative stress may be based on the change of FOXO1 trans-activation potential rather than the change of FOXO1 DNA-binding properties. Therefore, further investigations should be carried out to 
CONCLUSIONS
Here, we have first shown that apoA-I gene expression, protein synthesis, and secretion are decreased during H 2 O 2 -induced oxidative stress. This decline depends on the FOXO1 and LXRα transcription factors and on JNK, p38, and/or AMPK kinase cascades. We have first demonstrated that FOXO1 interacts with apoA-I hepatic enhancer and represses apoA-I gene activity. The similarities between inflammatory response, hypoxia, and oxidative stress are well known (Görlach et al. 2015) . ApoA-I protein is a negative marker of acute response; its synthesis is strongly downregulated under inflammation in hepatocytes, so the negative regulation of apoA-I gene expression under oxidative stress demonstrated Fig. 6 The relationships between AMPK cascade and FOXO1 and LXRα transcription factors in the hydrogen peroxide-mediated downregulation of apoA-I gene. a Real-time RT-PCR. HepG2 cells (96 well plate) were transfected with 2.4 pmoles per well of scrambled siRNA (black columns), siRNA against FOXO1 (white columns), siRNA against LXRα (light gray columns or siRNA against AMPKa (dark gray columns) for 72 h before RNA isolation and treated with 250 μM of H 2 O 2 for 24 h before RNA isolation. The activator of AMPK metformin (2 mM) was added 24 h before RNA isolation. Values are presented as means ± the standard error of the mean of four independent experiments. The statistical analyses of differences between compared groups were performed using a non-paired Student's t test (**p < 0.05) and Dunnett's criterion (#p < 0.05). b Western blotting analysis of subcellular localization of FOXO1 transcription factor. HepG2 cells were exposed to H 2 O 2 (250 μM) for 2 h. JNK inhibitor SP600125 (10 μM) had been added 1 h before hydrogen peroxide. Crude cytoplasmic and nuclear fractions were isolated as described in Materials and methods and analyzed by Western assay. β-actin in cytosolic fractions was used as a normalization control. Diagram shows the quantification of Western blotting by densitometry. The Y-axis values correspond to the ratio (%) of nuclear pool of the FOXO1 transcription factor to its total amount. The total amounts of the transcription factor were normalized by β-actin. Values are presented as means ± the standard error of the mean of three independent blots. The statistical analyses of differences between compared groups were performed using a non-paired Student's t test (**p < 0.05). c, d Real-time PCR calculation of ChIP. HepG2 cells were treated with hydrogen peroxide (250 μM) for 24 h. JNK inhibitor SP600125 (10 μM) had been added to cells 1 h before H 2 O 2 administration. Histograms represent the relative level of FOXO1 (c) or LXRα (d) binding (100% in control cells) to apoA-I hepatic enhancer (HE) (black columns). Primers to GAPDH genomic DNA were used as non-specificity control (gray columns). AB against β-actin were used as the control for nonspecific binding. Values are presented as means ± the standard error of the mean of three independent experiments. The statistical analyses of differences between compared groups were performed using a non-paired Student's t test. There are no significant differences between levels of FOXO1 and LXRα binding to apoA-I HE in the control cells and in the cells under an oxidative stress in this work is not surprising. Interestingly, both transcription factors responsible for H 2 O 2 -mediated repression of apoA-I gene-FOXO1 and LXRα take part in the TNFα-driven downregulation of apoA-I gene (Mogilenko et al. 2009; Orlov et al. 2010; Shavva et al. 2016a) . Reduced levels of plasma HDL are observed in cigarette smokers (Assmann et al. 1984) . Taking into account the known facts about high levels of generation of reactive oxygen species such as superoxides and hydrogen peroxide in cigarette smokers' plasma, our work suggests a molecular mechanism explaining a decline of HDL in cigarette smokers.
